August 31, 2016 10:22 PM ET

Pharmaceuticals

Company Overview of Itero Biopharmaceuticals, Inc.

Company Overview

As of August, 2011, Itero Biopharmaceuticals, Inc. went out of business. Itero Biopharmaceuticals, Inc. develops, manufactures and commercializes recombinant DNA-produced protein therapeutics. It provides recombinant follicle stimulating hormone for the treatment of female infertility. The company has a strategic partnership with Watson Pharmaceuticals, Inc. The company was founded in 2006 and is based in San Mateo, California. It has an additional location in Mountain View, California.

155 Bovet Road

Suite 660

San Mateo, CA 94402

United States

Founded in 2006

Phone:

650-581-7900

Fax:

650-581-7911

Key Executives for Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Itero Biopharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.